The patient, after NRP SPK, experienced short-term delayed pancreatic graft function requiring low-dose insulin treatment for 5 days post-transplant, most likely due to increased peripheral insulin resistance in obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.